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Background: The Brachyury (T) gene is required for the
formation of posterior mesoderm and for axial develop-
ment in both mouse and zebrafish embryos. In these
species, and in Xenopus, the gene is expressed transiently
throughout the presumptive mesoderm, and transcripts
then persist in notochord and posterior tissues. In Xenopus
embryos, expression of the Xenopus homologue of
Brachyury, Xbra, can be induced in presumptive ectoderm
by basic fibroblast growth factor (FGF) and activin; in the
absence of functional FGF or activin signalling pathways,
expression of the gene is severely reduced. Ectopic
expression of Xbra in presumptive ectoderm causes meso-
derm to be formed. As Brachyury and its homologues
encode sequence-specific DNA-binding proteins, it is
likely that each functions by directly activating down-
stream mesoderm-specific genes.
Results: We show that expression in Xenopus embryos
of RNA encoding a dominant-negative FGF receptor
inhibits the mesoderm-inducing activity of Xbra. We
demonstrate that ectopic expression of Xbra activates tran-
scription of the embryonic FGF gene, and that embryonic
FGF can induce expression of Xbra. This suggests that the
two genes are components of a regulatory loop. Consistent
with this idea, dissociation of Xbra-expressing cells causes a
dramatic and rapid reduction in levels of Xbra, but the
reduction can be inhibited by addition of FGF.
Conclusion: Formation of mesoderm tissue requires an
intact FGF signalling pathway downstream of Brachyury.
This requirement is due to a regulatory loop, in which
Brachyury activates expression of a member of the FGF
family, and FGF maintains expression of Brachyury. The
existence of this loop explains why embryos lacking an
FGF signalling pathway appear similar to those mutant
for Brachyury, and why over-expression of truncated
FGF receptors seems to inhibit induction of Brachyury
expression by activin.
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Background
The Brachyury (T) gene is required for the formation of
posterior mesoderm and for axial development in both
mouse and zebrafish embryos [1-4]. In all vertebrates,
the gene is initially expressed throughout the presump-
tive mesoderm, and transcripts then persist in notochord
and in posterior tissue [5,6]. In Xenopus embryos, expres-
sion of Xbra, the Xenopus homologue of Brachyury, can be
induced in presumptive ectoderm by the mesoderm-
inducing factors basic (b) fibroblast growth factor (FGF)
and activin [7]. If signalling in response to FGF or activin
is inhibited by over-expression of truncated versions of
the FGF or activin receptors, expression of Xbra in the
intact embryo is severely reduced [8-10]. Expression of
Xbra is also inhibited if cells of the Xenopus embryo are
dispersed during cleavage and blastula stages, thereby
disrupting cell-cell communication [11].
Over-expression of Xbra RNA in the presumptive ecto-
derm of Xenopus embryos causes ventral mesoderm for-
mation [12], and co-expression of Xbra with the noggin
gene, which encodes a secreted dorsalizing factor [13,14],
leads to the formation of dorsal tissues, such as notochord
and skeletal muscle [15]. Brachyury and its homologues
encode sequence-specific DNA-binding proteins [16],
suggesting that each exerts its mesoderm-inducing effects
by directly activating downstream mesoderm-specific
genes. In this study, however, we show that formation of
both dorsal and ventral mesoderm requires an intact FGF
signalling pathway downstream of Brachyury. This
requirement results from a regulatory loop, in which
Brachyury activates expression of a member of the FGF
family and FGF maintains expression of Brachyury. The
existence of this regulatory loop may explain why
embryos lacking a functional FGF signalling pathway [8]
appear so similar to those mutant for Brachyury [1,3]. It
also explains why over-expression of truncated FGF
receptors in the animal caps of Xenopus embryos seems to
inhibit the induction of Xbra expression by activin
[17-19]. Our results show that Xbra expression is induced
by activin under these circumstances, but that in the
absence of a functional FGF signalling pathway, Xbra
expression is not maintained. Finally, bearing this obser-
vation in mind, we discuss whether the apparent inhibi-
tion of Xbra expression in intact embryos that results
from over-expression of truncated FGF receptors [9]
similarly arises as a result of failure to maintain Xbra
transcription, rather than failure to induce transcription.
Results
Xenopus Brachyury function requires an intact FGF
signalling pathway
Over-expression of Xbra RNA in animal caps of Xenopus
embryos leads to formation of ventral mesoderm [12]. In
preliminary experiments, Xbra RNA was injected into
the animal pole regions of fertilized Xenopus eggs, either
alone or in the presence of RNA encoding a truncated
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FGF receptor (XFD) [8] or a truncated activin receptor
(AIXARI) [10]. Animal pole regions were dissected
from these embryos at the mid-blastula stage, cultured,
and assayed for extension movements. Explants derived
from embryos injected with Xbra RNA alone, or with
Xbra and A IXAR 1 RNAs, elongated slightly and differ-
entiated into vesicles containing mesenchyme, mesothe-
lium, and occasionally muscle. However, explants derived
from embryos injected with Xbra and XFD RNAs
showed no signs of mesoderm formation and differenti-
ated into atypical epidermis. This suggested that the
effects of Xbra require an intact FGF signalling pathway.
To investigate whether the same is true for Xbra function
in dorsal mesoderm, the experiment was repeated in the
presence of noggin RNA [13,14], which dorsalizes the
response to Xbra [15]. Over-expression of RNAs encod-
ing noggin, Xbra and HAVO, a non-functional form of
the FGF receptor, leads to elongation and the differentia-
tion of muscle, notochord and neural tissue (Fig. 1). The
same is true for explants derived from embryos injected
with noggin, Xbra and AIXAR1 RNAs (Fig. 1). In the
presence of XFD, encoding the truncated, dominant-
negative FGF receptor, however, explants do not elon-
gate or form mesoderm, but differentiate into neural
tissue and occasionally cement glands (Fig. 1). These tis-
sue types are observed after over-expression of noggin
RNA alone [15,20], and are also formed if noggin and
XFD RNAs are co-injected with AXbra RNA, encoding
a non-functional form of Xbra (Fig. 1).
Consistent with the findings of these morphological and
histological analyses, RNAase protection assays reveal
that cardiac actin RNA is expressed in explants derived
from embryos injected with Xbra, noggin and HAI/O, or
Xbra, noggin and AIXAR1 RNAs, but not in explants
over-expressing Xbra, noggin and XFD, the truncated
FGF receptor (Fig. 2). All explants injected with noggin
RNA express the neural marker N-CAM (Fig. 2), indi-
cating that XFD does not block noggin's function. Thus,
in both ventral and dorsal presumptive mesoderm, a
functional FGF receptor pathway, but not a functional
activin receptor pathway, is required downstream of Xbra
for normal Xbra function.
Xbra and embryonic FGF induce each other's expression
The simplest interpretation of these results is that Xbra
induces the expression of a member of the FGF family,
and that this molecule is necessary for Xbra function.
One potential target of Xbra is embryonic (e) FGF,
zygotic expression of which begins shortly before gastru-
lation [21], with transcripts then restricted to posterior
tissue in a pattern resembling the posterior expression of
Xbra. To investigate whether Brachyury induces the
expression of eFGF, RNA encoding Xbra or no tail (the
zebrafish Brachyury homologue) was injected into the ani-
mal pole regions of Xenopus embryos at the one-cell
stage. Animal caps were isolated at the mid-blastula stage,
cultured until the early gastrula stage (stage 11) and
assayed for expression of eFGF RNA by RNAase
Fig. 1. Xbra function is blocked by co-expression of RNA encod-
ing a truncated FGF receptor (XFD), but not a non-functional FGF
receptor (HAVe) or a truncated activin receptor (A1XARI).
Animal caps derived from embryos injected with the indicated
combinations of RNA were assayed for elongation (left-hand col-
umn) and for differentiation of mesodermal cell types (right-hand
column). Mesoderm formation in response to full-length Xbra
RNA is inhibited by XFD but not by HAVO or A1XAR1. The
neural-inducing effects of noggin are not inhibited by XFD.
Abbreviations: not, notochord; mus, muscle; neu, neural tissue;
cg, cement gland; epi, atypical epidermis.
protection. Both Xbra (not shown) and no tail induced
expression of eFGF (Fig. 3a).
The experiment described above indicates that Brachyury
activates expression of eFGF, a member of the FGF fam-
ily. A reciprocal influence of FGF family members on
Xbra expression might occur at either of two stages of
development. The first of these is before gastrulation. The
FGFs might act as mesoderm-inducing factors; treatment
of animal caps with bFGF is already known to induce
expression of Xbra [7] and we show here that eFGF has
the same effect (Fig. 3b). We also demonstrate that no tail
can induce expression of Xbra; animal caps derived from
embryos injected with no tail RNA go on to express Xbra
(Fig. 3b). This observation confirms previous results:
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Brachyury can induce its own expression [221. The auto-
induction is likely to occur indirectly, through induction
of eFGF expression, rather than by direct interaction of
the no tail product with the Xbra promoter, because ani-
mal caps derived from embryos over-expressing no tail in
Fig. 2. Animal caps derived from embryos injected with the
indicated combinations of RNA were assayed for expression of
muscle-specific cardiac actin RNA by RNAase protection.
Cardiac actin gene expression in response to full-length Xbra
RNA injection is inhibited by XFD, but not by HAV or
A1XAR1. The same RNA samples were also probed for expres-
sion of N-CAM. All explants derived from embryos injected with
noggin RNA express N-CAM, confirming that XFD does not
block the function of noggin.
the presence of XFD RNA do not activate transcription
of Xbra (our unpublished observations).
Maintenance of Xbra transcription requires FGF signalling
The second time during development at which FGF
family members might influence expression of Brachyury
is during gastrulation. Animal pole tissue loses the ability
to respond to FGF at the onset of gastrulation [23,24].
This loss of ability is correlated with the loss of functional
FGF receptors from animal pole cells at this time [25].
FGF receptors persist in presumptive mesoderm, how-
ever, and particularly in posterior tissue, where Xbra is
expressed [26]. This observation, together with the data
presented above, suggests that FGF signalling may be
involved in Xbra function at these stages. To investigate
this possibility, ventral and dorsal marginal zone tissue
was dissected from Xenopus embryos at the early gastrula
stage (stage 10.5), after the onset of Xbra expression [7].
Fig. 3. Induction of eFGF expression by Brachyury and induction
of Xbra expression by FGF family members and no tail. (a) Animal
caps derived from embryos injected with no tail RNA express
eFGF, whereas caps derived from uninjected embryos or from
embryos injected with RNA encoding a truncated form of Xbra
(AXbra) show no signal. (b) Animal caps derived from embryos
injected with RNA encoding eFGF or with no tail RNA express
Xbra. Exposure of animal cap explants to 20 U ml- soluble bFGF
served as a positive control (see 129] for definition of a unit of
mesoderm-inducing activity), whereas animal caps from control-
injected and uninjected embryos were used as negative controls.
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[17-19] or the mature region of the Vgl signalling pro-
tein [19]. Such explants do not exhibit extension move-
ments, and the induction of some mesodermal markers,
such as Xbra, seems to be inhibited. One interpretation
of this result is that the activin and Vgl signal transduc-
tion pathways require components of the FGF signalling
pathway. An alternative explanation, however, is that
induction of Xbra expression occurs in response to
activin, but that, in the absence of FGF signalling, this
expression of Xbra is only transient.
Fig. 4. FGF is required for the maintenance of Xbra expression.
Intact ventral and dorsal marginal zone tissue maintains Xbra
expression after culture to gastrula stages, whereas dissociated
marginal zone cells maintain expression only in the presence of
20 U ml-1 bFGF. Marginal zone regions were dissected at stage
10.5 and cultured to stage 12, either intact or in a dissociated state.
The tissue was then cultured intact or, in an effort to
dilute the effects of endogenous FGF, as dissociated cells.
Samples were collected 90 minutes after complete disso-
ciation of the explants (stage 12). Expression of Xbra per-
sisted in the intact marginal tissue, but had fallen almost
to undetectable levels in dissociated cells (Fig. 4).
Addition of bFGF to the dissociated cells, however,
maintained expression of Xbra (Fig. 4).
Activin-mediated induction of Xbra does not require
FGF signalling
The observation that the FGF signalling pathway is
required for maintenance of Xbra expression sheds light
on experiments in which animal pole explants derived
from XFD-injected embryos are exposed to activin
We examined this possibility by applying activin to
animal pole explants derived from XFD-injected
embryos (expressing the truncated FGF receptor) and
assaying for expression of Xbra at intervals thereafter
(Fig. 5). Expression of Xbra was consistently observed
200 minutes after exposing caps to activin, demonstrating
that activin can induce expression of Xbra in the absence
of a functional FGF signalling pathway. Transcripts
became undetectable within 60 minutes, however, indi-
cating that, under these circumstances, Xbra RNA
undergoes very rapid turnover. This rapid turnover may
account for the low initial level of expression of Xbra
observed in these experiments (Fig. 5).
Discussion
Our data indicate that Xbra and eFGF are components of
a regulatory loop, in which each can induce expression
of the other, and in which eFGF (or another member of
the FGF family) maintains expression of Xbra. This loop
is required for the mesoderm-inducing effects of Xbra,
because if it is disrupted, by interfering with FGF
signalling, mesoderm formation is blocked. These results
are consistent with data recently reported by Isaacs and
colleagues [27], who also demonstrated that Xbra induces
eFGF expression and that dissociation of marginal zone
tissue causes a decline in levels of Xbra. Our data add to
theirs, however, by demonstrating that expression of
Fig. 5. The FGF receptor pathway is
required for maintenance, but not for
initiation, of activin-induced expression
of Xbra. Animal caps derived from
embryos injected with XFD or HAVO at
the one-cell stage were incubated in
12 U ml-1 activin from stage 8 and har-
vested at the indicated times (see [291
for the definition of a unit of mesoderm-
inducing activity). As a negative control,
animal caps were dissected from unin-
jected embryos and cultured in the
absence of activin. Activin causes per-
sistent expression of Xbra in animal
caps derived from embryos injected
with HAVO RNA, but only transient
expression in caps derived from
embryos injected with XFD RNA. This
experiment has been performed three
times, with identical results.
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eFGF is a very rapid response to Xbra, and that levels of
Xbra decline precipitously if FGF signalling is inhibited.
Furthermore, co-expression of Xbra mRNAs with XFD,
encoding the truncated dominant-negative FGF recep-
tor, enables us to demonstrate unequivocally that FGF
signalling is a downstream requirement for Xbra function.
These results raise several issues.
FGF and the Brachyury mutant phenotype
The existence of the regulatory loop described in this
paper may explain, at least in part, why the phenotypes
of embryos lacking components of the FGF signalling
pathway are similar to those mutant for Brachyury or its
homologues [1,3,8]. In both cases, embryos lack a differ-
entiated notochord and posterior structures, although
head structures are unaffected. But Xenopus embryos
expressing truncated FGF receptors usually have no
somites [8], whereas mutant mouse embryos have seven
somites [1] and mutant fish embryos have 17-19 somites
[3]. Whether the complete absence of somites in Xenopus
embryos represents a species difference, or whether FGF
signalling is also required for the formation of the most
anterior somites, remains to be seen.
The proposed regulatory loop involving Brachyury and a
member of the FGF family would also be disrupted by
the absence of functional Brachyury protein, and we note
that in both mouse and zebrafish embryos mutant for
Brachyury, levels of Brachyury RNA are reduced [4,5]. It
will be important to examine whether a homologue of
Xenopus eFGF exhibits reduced levels of expression in
Brachyury mutant mouse and zebrafish embryos.
Implications for other experiments involving truncated FGF
receptors or dissociation procedures
Our conclusion that FGF signalling is required for the
maintenance of activin-induced expression of Xbra, but
not for the initial activation of the gene, has several impli-
cations. First, as discussed above, it suggests that the
activin signal transduction pathway does not require com-
ponents of the FGF signalling pathway. In addition, the
finding affects the interpretation of several recent experi-
ments involving the dispersal of embryonic cells. Lemaire
and Gurdon [11], for example, have shown that Xbra tran-
scripts cannot be detected in cells derived from embryos
that are kept dissociated from the morula stage to the
early gastrula stage. By contrast, expression of goosecoid
and Xwnt-8 does occur. This may mean that expression of
goosecoid and Xwnt-8 is controlled differently from the
expression of Xbra, but an alternative explanation is that
activation of Xbra occurs in these experiments, but in the
absence of cell-cell contact, and therefore of FGF sig-
nalling, this expression is weak and transient.
It is also possible that the apparent lack of Xbra expression
in embryos over-expressing truncated FGF receptors [9]
reflects a lack of maintenance of expression, rather than
inhibition of the initial activation of the gene. If this were
the case, there might be a brief period of expression of
Xbra at early gastrula stages, followed by a rapid decline
in transcript levels. We have investigated this question
using the sensitive technique of RNAase protection, but
at no stage do we observe complete extinction of Xbra
expression. We do not know whether this is due to
incomplete blockage of FGF signalling, or whether other
mesoderm-inducing factors, such as activin, Vgl or
BMP-4, are inducing Xbra expression.
Conclusions
The data in this paper show that the FGF receptor
signalling pathway is required for maintenance of the
expression of Xbra, and therefore for Xbra function. We
provide evidence for a regulatory loop in which Xbra
activates expression of a member of the FGF family and
FGF maintains expression of Xbra. These findings add sig-
nificantly to our understanding of the roles of Brachyury
and its homologues, and of the FGF family of signalling
molecules, in vertebrate early development, and will help
in the interpretation of other experiments involving over-
expression of dominant-negative FGF receptors, or
experiments involving dissociation procedures.
Materials and methods
RNA injections and processing of explants
Various combinations of synthetic RNAs (1 ng Xbra ; 0.6 ng
AXbra; I ng no tail; 100 pg noggin; 1 ng A 1XARI; 1 ng XFD;
1 ng HA VO) were injected into the animal pole regions of
Xenopus embryos at the one-cell stage. Animal caps were
dissected at stage 8 [28] and cultured to stage 15 for morpho-
logical analysis, stage 40 for histological analysis, or to the stages
indicated in the text for RNAase protection analyses. Synthesis
of RNA, microinjection, histological analysis and RNAase
protection assays were carried out as described [19].
Dissociation of marginal zones
Marginal zone regions were dissected at stage 10.5 and dissoci-
ated. Dissociation was carried out in CMFME (44 mM NaCI,
2.5 mM sodium phosphate, pH 7.5, 0.1 mM KCI, 0.5 mM
EDTA), and was complete by stage 11. Where appropriate,
20 U ml- ' bFGF was added to the CMFME. Samples were
collected after 90 min, when controls had reached stage 12.
Intact marginal zones were cultured in 75 % normal amphibian
medium (NAM [24]).
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